Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer

Detalles Bibliográficos
Autores principales: Bertucci, François, De Nonneville, Alexandre, Finetti, Pascal, Mamessier, Emilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397558/
https://www.ncbi.nlm.nih.gov/pubmed/37278484
http://dx.doi.org/10.1002/cac2.12447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397558/
https://www.ncbi.nlm.nih.gov/pubmed/37278484
http://dx.doi.org/10.1002/cac2.12447

Ejemplares similares